{"title":"Correction to “Role and Regulation of Proapoptotic Bax in Oral Squamous Cell Carcinoma and Drug Resistance”","authors":"","doi":"10.1002/hed.27959","DOIUrl":null,"url":null,"abstract":"<p>Alam M, Kashyap T, Mishra P, Panda AK, Nagini S, Mishra R. Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance. <i>Head & Neck</i>. 2019; 41: 185–197. https://doi.org/10.1002/hed25471.</p><p>We apologize for these errors.</p><p><b>FIGURE 6</b> | Bax expression in oral squamous cell carcinoma (OSCC) and its correlation with p53, Bcl-2, and p-Akt during OSCC progression and resistance. (A–R) Representative immunostaining showing the differential expression of Bax, p53, and p-Akt proteins in adjacent samples of adjacent normal, primary tumor, and resistance to chemoradiation therapy (RCRT) as indicated in the figure. (S) The correlation of Bax with p53 and p-Akt proteins (detected by immunostaining) in all samples and in RCRT group of samples, as shown in the figure. [Color figure can be viewed at wileyonlinelibrary.com]</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":"47 1","pages":"414-417"},"PeriodicalIF":2.2000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hed.27959","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hed.27959","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Alam M, Kashyap T, Mishra P, Panda AK, Nagini S, Mishra R. Role and regulation of proapoptotic Bax in oral squamous cell carcinoma and drug resistance. Head & Neck. 2019; 41: 185–197. https://doi.org/10.1002/hed25471.
We apologize for these errors.
FIGURE 6 | Bax expression in oral squamous cell carcinoma (OSCC) and its correlation with p53, Bcl-2, and p-Akt during OSCC progression and resistance. (A–R) Representative immunostaining showing the differential expression of Bax, p53, and p-Akt proteins in adjacent samples of adjacent normal, primary tumor, and resistance to chemoradiation therapy (RCRT) as indicated in the figure. (S) The correlation of Bax with p53 and p-Akt proteins (detected by immunostaining) in all samples and in RCRT group of samples, as shown in the figure. [Color figure can be viewed at wileyonlinelibrary.com]
Alam M, Kashyap T, Mishra P, Panda AK, Nagini S, Mishra R.促凋亡因子Bax在口腔鳞状细胞癌和耐药中的作用及调控。头,脖子。2019;41: 185 - 197。https://doi.org/10.1002/hed25471.We为这些错误道歉。图6口腔鳞状细胞癌(OSCC)中|的表达及其与p53、Bcl-2和p-Akt在OSCC进展和耐药过程中的相关性。(A-R)代表性免疫染色显示Bax、p53和p-Akt蛋白在相邻正常、原发肿瘤和放化疗耐药(RCRT)的相邻样本中的差异表达,如图所示。(S)所有样品和RCRT组样品中Bax与p53、p-Akt蛋白(免疫染色检测)的相关性如图所示。[彩色图可在wileyonlinelibrary.com查看]
期刊介绍:
Head & Neck is an international multidisciplinary publication of original contributions concerning the diagnosis and management of diseases of the head and neck. This area involves the overlapping interests and expertise of several surgical and medical specialties, including general surgery, neurosurgery, otolaryngology, plastic surgery, oral surgery, dermatology, ophthalmology, pathology, radiotherapy, medical oncology, and the corresponding basic sciences.